These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 18950981

  • 1. Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors.
    Clunie GP, Clark A, Mortimer CJ, Stephenson S, Aitken J, Smith C, Sherwin E, Archer TJ.
    Eur J Surg Oncol; 2009 May; 35(5):475-80. PubMed ID: 18950981
    [Abstract] [Full Text] [Related]

  • 2. Emerging bone health issues in women with breast cancer in Hawai'i.
    Carney JF, Davis J.
    Hawaii Med J; 2007 Jun; 66(6):164-6. PubMed ID: 17621865
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM, Doughty J, Eastell R, Heys SD, Howell A, McCloskey EV, Powles T, Selby P, Coleman RE.
    Cancer Treat Rev; 2008 Jun; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [Abstract] [Full Text] [Related]

  • 5. Aromatase inhibitors and bone health.
    Bundred NJ.
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):60-7. PubMed ID: 19125005
    [Abstract] [Full Text] [Related]

  • 6. [Effect of aromatase inhibitors on bone metabolism].
    Folkestad L, Bjerregaard JK, Bjarnason NH, Brixen KT.
    Ugeskr Laeger; 2007 May 07; 169(19):1774-9. PubMed ID: 17537350
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL, Song J, Dowsett SA, Mershon JL, Delmas PD, Secrest RJ, Cauley JA.
    Curr Med Res Opin; 2008 Mar 07; 24(3):807-13. PubMed ID: 18254988
    [Abstract] [Full Text] [Related]

  • 10. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
    Brufsky A, Bundred N, Coleman R, Lambert-Falls R, Mena R, Hadji P, Jin L, Schenk N, Ericson S, Perez EA, Z-FAST and ZO-FAST Study Groups.
    Oncologist; 2008 May 07; 13(5):503-14. PubMed ID: 18515735
    [Abstract] [Full Text] [Related]

  • 11. Effects of third-generation aromatase inhibitors on bone.
    McCloskey E.
    Eur J Cancer; 2006 May 07; 42(8):1044-51. PubMed ID: 16554149
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reducing the risk of cancer treatment-associated bone loss in patients with breast cancer.
    Hadji P, Bundred N.
    Semin Oncol; 2007 Dec 07; 34(6 Suppl 4):S4-10. PubMed ID: 18068489
    [Abstract] [Full Text] [Related]

  • 14. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr 07; 17(94):68-72. PubMed ID: 18536138
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients.
    Yonehara Y, Iwamoto I, Kosha S, Rai Y, Sagara Y, Douchi T.
    J Obstet Gynaecol Res; 2007 Oct 07; 33(5):696-9. PubMed ID: 17845332
    [Abstract] [Full Text] [Related]

  • 17. Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies.
    Coleman RE, Body JJ, Gralow JR, Lipton A.
    Cancer Treat Rev; 2008 Oct 07; 34 Suppl 1():S31-42. PubMed ID: 18486346
    [Abstract] [Full Text] [Related]

  • 18. Osteoporosis risk in premenopausal women.
    Vondracek SF, Hansen LB, McDermott MT.
    Pharmacotherapy; 2009 Mar 07; 29(3):305-17. PubMed ID: 19249949
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.